Gene may fend off prions
Part of a prion, the protein implicated in vCJD
A gene may protect people against variant Creutzfeldt-Jakob disease.
People who lack a gene involved in immune responses may be three times more likely to suffer from variant Creutzfeldt-Jakob disease (vCJD), a new study suggests1. The result, if borne out in larger studies, could point researchers toward therapies for the incurable brain disease.
vCJD is thought to occur when people are exposed to misshapen prion proteins from cows with bovine spongiform encephalopathy - BSE or ’mad cow disease’. The gene does not appear to protect against the sporadic form of the disease (CJD).
Of 50 patients with vCJD - about half of those known to have the disease - only 12% have a gene called DQ7, John Collinge of Imperial College School of Medicine in London and his colleagues have found. In contrast, 36% of the normal population has the gene.
The small number of participants makes it difficult to draw conclusions from the study, experts warn. "These kinds of studies are very susceptible to false positive findings," says Cornelia van Duijn, a genetic epidemiologist at Erasmus University Medical School in Rotterdam.
But, by shedding light on susceptibility to the disease, the study could improve estimates of how many people will develop it, van Duijn adds.
It would take something like 500 patients - many more than have been diagnosed - to get truly reliable findings, says Stephen O’Brien, a geneticist at that US National Cancer Institute in Maryland. Nonetheless, he says, "the results are provocative and make us want to know if they’re right".
It would be good to test a larger sample, agrees Collinge.
Although the findings do not point to any immediate therapy for the disease they could help researchers looking for treatments. "If we can understand why DQ7 is important in protecting against vCJD, it might open up new avenues to treatment," Collinge says.
- Jackson, G. S. et al. HLA-DQ7 antigen and resistance to variant CJD. Nature, 414, 269 - 270, (2001).
ERICA KLARREICH | © Nature News Service
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.
The results will be published on March 22 in the journal „Astronomy & Astrophysics“.
Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...
Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.
Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...
Layered 2D material improves efficiency for solar cells and LEDs
In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.
Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.
Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...